Rankings
▼
Calendar
MESO Q4 2016 Earnings — Mesoblast Limited Revenue & Financial Results | Market Cap Arena
MESO
Mesoblast Limited
$2B
Q4 2016 Earnings
Healthcare
Biotechnology
Income Statement
Revenue
$27M
Gross Profit
$19M
71.3% margin
Operating Income
$36M
134.6% margin
Net Income
$48M
179.7% margin
EPS (Diluted)
$0.90
QoQ Revenue Growth
+548.9%
Cash Flow
Operating Cash Flow
-$18M
Free Cash Flow
-$18M
Stock-Based Comp.
$1M
Balance Sheet
Total Assets
$684M
Total Liabilities
$156M
Stockholders' Equity
$528M
Cash & Equivalents
$22M
← FY 2016
All Quarters
Q1 2017 →
